This release comes as we also see Cyberpunk 2077 mods that alter the range of facial features, change your looks in small ways after character creation, and even access stuff we were never meant ...

Eli Lilly is still celebrating the FDA approval of its amyloid-directed Alzheimer's therapy Kisunla but has had less fortune with a candidate against tau, another well-established drug target for ...

Roche has doubled its anti-tau pipeline for Alzheimer’s disease, paying $120m upfront for rights to UCB’s UCB0107 candidate that will serve as a back-up to its own semorinemab in phase 2 ...